| 產品編號 | bs-41180P |
| 英文名稱 | Recombinant human FABP3 protein, His |
| 中文名稱 | 重組人心型脂肪酸結合蛋白/脂肪酸結合蛋白3蛋白 |
| 別 名 | MDGI; FABP11; H-FABP; M-FABP; O-FABP; Fatty acid-binding protein, heart; Fatty Fatty acid-binding protein 3; Heart-type fatty acid-binding protein (H-FABP); Mammary-derived growth inhibitor (MDGI); Muscle fatty acid-binding protein (M-FABP); FABPH_HUMAN; Cardiac FABP; Recombinant human FABP3 protein, His |
| 理論分子量 | 15kDa |
| 檢測分子量 | 15-17 |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | ＞0.5 mg/ml |
| 物 種 | Human |
| 序 列 | 2-133/133 |
| 純 度 | >95% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內毒素 | Not analyzed |
| 表達系統 | E.coli |
| 活性 | Not tested |
| 標簽 | His |
| 緩 沖 液 | 20mM Tris-HCl (pH8.0) with 150mM NaCl and 100mM imidazole. |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 |
Fatty acid-binding proteins, designated FABPs, are a family of homologous cytoplasmic proteins that are expressed in a highly tissue-specific manner and play an integral role in the balance between lipid and carbohydrate metabolism. FABPs mediate fatty acid (FA) and/or hydrophobic ligand uptake, transport and targeting within their respective tissues. The mechanisms underlying these actions can give rise to both passive diffusional uptake and protein-mediated transmembrane transport of FAs. FABPs are expressed in adipocytes (A-FABP), brain (B-FABP), epidermis (E-FABP, also designated psoriasis-associated FABP or PA-FABP), muscle and heart (H-FABP, also designated mammary-derived growth inhibitor or MDGI), intestine (I-FABP), liver (L-FABP), myelin (M-FABP) and testis (T-FABP). MDGI is highly expressed in the myocardium, skeletal and smooth muscle fibers, lipid and/or steroid synthesizing cells and terminally differentiated epithelia of the respiratory, intestinal and urogenital tracts. SWISS: P05413 Gene ID: 2170 |
| 產品圖片 |
Recombinant human Cardiac FABP in SDS-page
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
|
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
